Department of Urological Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
School of Medicine, Nantong University, Nantong, Jiangsu 226001, China.
Oxid Med Cell Longev. 2022 Oct 10;2022:2435114. doi: 10.1155/2022/2435114. eCollection 2022.
This study further explored LINC00958's role in promoting tumor angiogenesis (AG) and oxidative stress (OS) development by inhibiting BC cell autophagy through sponge adsorption of miR-625-5p.
BC patients and healthy controls who visited our hospital between June 2017 and February 2019 were selected as the research group (RG) and the control group (CG), respectively, with a total of 133 study subjects. Peripheral blood LINC00958 and miR-625-5p in both cohorts of participants were detected. Additionally, human bladder transitional cell carcinoma cells (T24 and J82) and human normal urothelial cells (SV-HUC-1) were purchased. Alterations in cell biological behavior were observed after transfecting miR-625-5p-mimics, miR-625-5p-inhibition, and miR-625-5p-NC sequences into these cells, respectively. Besides, ELISA was performed to quantify inflammatory factors (IFs), AG indicators, and OS indexes in cells. Subsequently, a double luciferase reporter (DLR) assay was performed to verify the targeting relationship between LINC00958 and miR-625-5p. Finally, BALB/c-nu nude mice were purchased, and T24 cells transfected with silenced LINC00958 and miR-625-5p expression sequences were used to establish subcutaneous tumors to observe tumor growth and pathological changes.
RG exhibited higher LINC00958 and lower miR-625-5p than CG. LINC00958 and miR-625-5p were strongly linked to myometrial invasion (MI), lymph node metastasis (LNM), distant metastasis (DM), and histology in BC patients, and the increase of LINC00958 and the decrease of miR-625-5p predicted an increased risk of prognostic death in such patients. After miR-625-5p inhibition, the capacity of BC cells to proliferate, invade, and migrate enhanced and the AG, inflammatory response, and OS injury increased, while the apoptosis rate and autophagy ability decreased. The DLR assay revealed inhibited LINC00958WT fluorescence activity by miR-625-5p-mimics, while the biological behavior of BC cells cotransfected with sh-LINC00958 and miR-625-5p-inhibition had no difference with the functions of sh-control and miR-625-5p-NC cotransfected cells. Finally, the nude mouse tumorigenesis experiment showed that the tumor mass, volume, and histopathological features of the sh-LINC00958 group were decreased compared with the sh-control group, while those of the miR-625-5p-inhibition group were increased versus miR-625-5p-NC.
In BC, LINC00958 is highly expressed while miR-625-5p is underexpressed. LINC00958 can inhibit cell autophagy to enhance cell activity; promote OS, inflammation, and AG; and regulate tumor immunity by targeting miR-625-5p, thus participating in the development of BC.
本研究通过海绵吸附 miR-625-5p 抑制 BC 细胞自噬,进一步探讨 LINC00958 通过抑制 miR-625-5p 促进肿瘤血管生成 (AG) 和氧化应激 (OS) 发展的作用。
选择 2017 年 6 月至 2019 年 2 月期间我院就诊的 BC 患者和健康对照者分别作为研究组 (RG) 和对照组 (CG),共纳入 133 例研究对象。检测两组参与者的外周血 LINC00958 和 miR-625-5p。此外,还购买了人膀胱移行细胞癌细胞 (T24 和 J82) 和人正常尿路上皮细胞 (SV-HUC-1)。分别转染 miR-625-5p-模拟物、miR-625-5p 抑制物和 miR-625-5p-NC 序列后观察这些细胞的细胞生物学行为变化。此外,采用 ELISA 法测定细胞中炎症因子 (IFs)、AG 指标和 OS 指标。随后,进行双荧光素酶报告 (DLR) 检测验证 LINC00958 和 miR-625-5p 之间的靶向关系。最后,购买 BALB/c-nu 裸鼠,将沉默 LINC00958 和 miR-625-5p 表达序列的 T24 细胞转染用于建立皮下肿瘤,观察肿瘤生长和病理变化。
RG 组的 LINC00958 高于 CG 组,miR-625-5p 低于 CG 组。LINC00958 和 miR-625-5p 与 BC 患者的肌层浸润 (MI)、淋巴结转移 (LNM)、远处转移 (DM) 和组织学密切相关,LINC00958 的增加和 miR-625-5p 的减少预示着此类患者预后死亡风险增加。抑制 miR-625-5p 后,BC 细胞的增殖、侵袭和迁移能力增强,AG、炎症反应和 OS 损伤增加,而细胞凋亡率和自噬能力下降。DLR 检测显示 miR-625-5p-模拟物抑制了 LINC00958WT 的荧光活性,而共转染 sh-LINC00958 和 miR-625-5p 抑制物的 BC 细胞的生物学行为与共转染 sh 对照和 miR-625-5p-NC 的细胞的功能没有差异。最后,裸鼠肿瘤发生实验显示,与 sh 对照相比,sh-LINC00958 组的肿瘤质量、体积和组织病理学特征减少,而 miR-625-5p 抑制组的肿瘤质量、体积和组织病理学特征增加。
在 BC 中,LINC00958 高表达而 miR-625-5p 低表达。LINC00958 可通过抑制细胞自噬来增强细胞活性;促进 OS、炎症和 AG;并通过靶向 miR-625-5p 调节肿瘤免疫,从而参与 BC 的发展。